For decades, people with diabetes have relied on finger pricks to withdraw blood or adhesive microneedles to measure and manage their glucose levels.
Bionomics’ stock skyrockets 340% after PTSD candidate passes PhIIb test
Bionomics touted the registrational potential of its post-traumatic stress disorder drug after it hit the primary endpoint in a Phase IIb trial, triggering the company’s
September 29, 2023